GlassScriptPhysician profile
Chase Ranker
NPI 1275891996
$3,483.52
in general payments reported to CMS, 2019-2025
12 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,204 · 2020: $138 · 2021: $188 · 2022: $167 · 2023: $239 · 2024: $133 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $1,460.00 | 2019 | |
| Stryker Corporation | $877.39 | 2019-2025 | Variax, Citrefix, Augment Injectable |
| Organogenesis INC. | $420.77 | 2020-2025 | Puraply, Puraply Wound Matrix |
| Smith+Nephew, INC. | $268.40 | 2019-2025 | Grafix Pl |
| Integra Lifesciences Corporation | $243.51 | 2019-2022 | |
| Kerecis Limited | $115.48 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $25.55 | 2025 | |
| Paragon 28, INC. | $22.96 | 2019 | |
| Solventum Corporation | $16.36 | 2025 | Activ.A.C. |
| Aroa Biosurgery Incorporated | $14.37 | 2019 | |
| Depuy Synthes Sales INC. | $12.36 | 2022 | |
| Lifenet Health | $6.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Ranker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.